The earnings are surely disappointing, reduced quite a bit when compared to previous quarters
One reason I can think of would be the decrease in revenue in commercial services (The management has mentioned it would drop compared to 2021) Also, with the product side, sales haven't been picked up yet.
Seems like FDA for Febridx is still some time away, and we only have Canada for the Covidx test. I don't understand why there wasn't an announcement for the 5m USD additional order from Canada, that's some quite significant revenue for LDX
The earnings are surely disappointing, reduced quite a bit when...
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.06M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.1¢ | 4.9¢ | $124.1K | 2.483M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 217509 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 469754 | 4 |
View Market Depth
| Last trade - 13.12pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.9¢ |
Change
0.000 ( 2.08 %) |
||||
| Open | High | Low | Volume | ||
| 4.9¢ | 5.1¢ | 4.9¢ | 403007 | ||
| Last updated 13.12pm 03/05/2024 ? | |||||
| LDX (ASX) Chart |